Overview

This bill proposes to legalize supervised drug consumption facilities (SDCFs) in the UK. These facilities would provide a safe, medically supervised environment for individuals to use controlled substances, aiming to reduce drug-related deaths and harm.

Description

The bill establishes a licensing system for local authorities to operate SDCFs. Applicants must demonstrate the suitability of their personnel, premises, and operational protocols. The Secretary of State, in consultation with relevant NHS bodies, will assess applications, considering local need and potential impact. The bill also amends the Misuse of Drugs Act 1971 to exempt authorized users and facility staff from prosecution for drug possession and use within licensed SDCFs. The Secretary of State will produce an annual report monitoring drug-related deaths, on-street injecting, needle infections, and the impact of SDCFs on these metrics.

Government Spending

The bill mandates that any expenditure incurred by the Secretary of State in implementing the Act, along with any increases in existing spending attributable to the Act, will be funded by Parliament. Specific financial figures are not provided in the bill text.

Groups Affected

• Injecting drug users: Potentially reduced risk of overdose and infection through access to medically supervised consumption.
• Local authorities: Opportunity to apply for licenses to operate SDCFs, potentially incurring costs and responsibilities.
• Healthcare professionals: Increased workload related to the operation and supervision of SDCFs.
• Law enforcement: Changes in enforcement of drug laws within the context of licensed SDCFs.
• Communities: Potential for both positive (reduced drug-related harm) and negative (concerns about location and potential increase in drug use in the vicinity) impacts depending on the location and operation of facilities.

Powered by nyModel